XML 16 R6.htm IDEA: XBRL DOCUMENT v3.21.2
Consolidated Statements of Changes in Equity - USD ($)
shares in Millions, $ in Millions
Total
Ordinary Shares [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
AOCI Attributable to Parent [Member]
Treasury Shares [Member]
Total Teva Shareholders' Equity [Member]
Non-controlling Interests [Member]
Beginning balance at Dec. 31, 2019 $ 15,063 $ 56 $ 27,312 $ (6,956) $ (2,312) $ (4,128) $ 13,972 $ 1,091
Beginning balance, shares at Dec. 31, 2019   1,198            
Net Income (loss) (4,261)     (4,140)     (4,140) (121)
Other comprehensive income (loss) (302)       (331)   (331) 29
Issuance of Shares, shares   4            
Stock-based compensation expense 91   91       91  
Ending balance at Sep. 30, 2020 10,592 $ 57 27,403 (11,096) (2,643) (4,128) 9,593 999
Ending balance, shares at Sep. 30, 2020   1,202            
Beginning balance at Jun. 30, 2020 14,824 $ 57 27,374 (6,747) (2,703) (4,128) 13,852 972
Beginning balance, shares at Jun. 30, 2020   1,202            
Net Income (loss) (4,340)     (4,349)     (4,349) 10
Other comprehensive income (loss) 79       61   61 18
Stock-based compensation expense 29   29       29  
Ending balance at Sep. 30, 2020 10,592 $ 57 27,403 (11,096) (2,643) (4,128) 9,593 999
Ending balance, shares at Sep. 30, 2020   1,202            
Beginning balance at Dec. 31, 2020 11,061 $ 57 27,443 (10,946) (2,399) (4,128) 10,026 1,035
Beginning balance, shares at Dec. 31, 2020   1,202            
Net Income (loss) 608     576     576 32
Other comprehensive income (loss) (302)       (221)   (221) (81)
Issuance of Shares, shares   7            
Stock-based compensation expense 86   86       86  
Ending balance at Sep. 30, 2021 11,451 $ 57 27,529 (10,370) (2,620) (4,128) 10,467 984
Ending balance, shares at Sep. 30, 2021   1,209            
Beginning balance at Jun. 30, 2021 11,311 $ 57 27,503 (10,662) (2,446) (4,128) 10,324 987
Beginning balance, shares at Jun. 30, 2021   1,209            
Net Income (loss) 302     292     292 11
Other comprehensive income (loss) (187)       (174)   (174) (13)
Stock-based compensation expense 26   26       26  
Ending balance at Sep. 30, 2021 $ 11,451 $ 57 $ 27,529 $ (10,370) $ (2,620) $ (4,128) $ 10,467 $ 984
Ending balance, shares at Sep. 30, 2021   1,209